Daicel Arbor Biosciences Announces Ravindra Ramadhar as its new president
Daicel Arbor Biosciences Expands Leadership and Announces Ravindra Ramadhar as its new President
Ann Arbor, MI (July 1, 2022) – Daicel Arbor Biosciences, a division of Daicel Chiral Technologies, and leader in developing molecular biology research tools, is pleased to introduce Ravindra Ramadhar as its new President.
Previously Mr. Ramadhar was Director, Strategy & Business Development within Thermo Fisher Scientific’s Genetics Science Division. Ramadhar brings a vast technical background to Daicel Arbor Biosciences with his prior experience as a director in the life and genetic sciences sectors, specifically focusing on applied markets in Agribusiness. His leadership will positively impact Daicel Arbor’s vision, strategy and portfolio development.
Mr. Ramadhar earned a Master of Business Administration (M.B.A.) from Whitman School of Management, Syracuse University, and Bachelor of Science from Rutgers University. He also received many hours of executive education from various programs at Harvard University.
With the addition of Mr. Ramadhar to the team, Daicel Arbor’s current President, Joseph M. Barendt, Ph.D., will continue to serve as President of Daicel Chiral Technologies and shift his attention to strategic growth projects within the newly formed Life Sciences Business area of Daicel Group. “I am excited to add someone of Mr. Ramadhar’s depth of experience, enthusiasm and leadership skills to the Daicel Arbor team and look forward to working closely with him over the coming years.”
Ramadhar adds “Daicel Arbor Biosciences’ extensive capabilities in genomics and tools for synthetic biology coupled with its passion for science provide a strong foundation for growth. Daicel Arbor Biosciences’ solutions enable genomics and synthetic biology researchers to answer key biological questions, advancing their research goals.”